Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Iptacopan for Patients with Complement 3 Glomerulopathy
The NetherlandsComparison of nilotinib versus imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission
The NetherlandsStudy on the Effectiveness and Safety of Mitapivat in Children with Pyruvate Kinase Deficiency Not Receiving Regular Blood Transfusions
The NetherlandsStudy on the Effectiveness and Safety of Avalglucosidase Alfa for Babies with Infantile-Onset Pompe Disease
The NetherlandsStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
The NetherlandsStudy on Gout Treatment: Comparing Allopurinol, Benzbromarone, and Febuxostat in Patients with Gout in Remission
The NetherlandsStudy of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History
The NetherlandsStudy of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation
The NetherlandsStudy of iberdomide alone or with drug combinations for patients with multiple myeloma: testing safety and effectiveness of different doses
The NetherlandsStudy on the Effectiveness and Safety of AC102 Injection vs. Oral Prednisolone for Patients with Sudden Hearing Loss
The NetherlandsStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
The NetherlandsStudy on Trastuzumab Deruxtecan for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
